Hemolytic Uremic Syndrome (HUS) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Gene Mutations Affect Kidney Disease Risk And Prognosis
Screening could help in the diagnosis and treatment of affected individuals Highlights Certain mutations and combinations of mutations in immune-related genes affect individuals' risk of developing a rare but serious kidney condition. These mutations also affect patient prognosis following different treatments. About half of patients with the condition, called atypical hemolytic uremic syndrome, develop kidney failure... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 25, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news

Molecular basis identified for tissue specific immune regulation in the eye and kidney
(University of Manchester) Scientists at The University of Manchester have made important advances in understanding why our immune system can attack our own tissues resulting in eye and kidney diseases. It is hoped the research will pave the way for the development of new treatments for the eye condition age-related macular degeneration and the kidney condition atypical Haemolytic Uremic Syndrome. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 20, 2013 Category: Biology Source Type: news

Advisory Group for National Specialised Services (AGNSS) issues statement on eculizumab for treatment of atypical haemolytic uraemic syndrome
Source: NHS Specialised Services Area: News The Advisory Group for National Specialised Services (AGNSS) provides advice to Ministers on which services and technologies should be nationally commissioned and which providers should be designated to deliver them. It considered the applications for eculizumab for the treatment of atypical haemolytic uraemic syndrome and concluded that it would help save lives and improve the quality of life for children (among whom the condition is particularly prevalent) and adults. However, ministers have decided not to recommend national commissioning of this treatment, and as AGNSS ceases...
Source: NeLM - News - January 24, 2013 Category: Drugs & Pharmacology Source Type: news